Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024224319> ?p ?o ?g. }
- W2024224319 endingPage "3536" @default.
- W2024224319 startingPage "3525" @default.
- W2024224319 abstract "The metabolism of arachidonic acid by the cyclooxygenase (COX) or lipoxygenase (LO) pathways generates eicosanoids that have been implicated in the pathogenesis of a variety of human diseases, including cancer. In this study, we examined the expression and significance of components within the 5-LO pathway in human neuroblastoma, an embryonal tumor of the sympathetic nervous system. High expression of 5-LO, 5-LO-activating protein (FLAP), leukotriene A(4) hydrolase, leukotriene C(4) synthase, and leukotriene receptors was detected in a majority of primary neuroblastoma tumors and all cell lines investigated. Expression of 5-LO and FLAP was evident in tumor cells but not in nonmalignant adrenal medulla where neuroblastomas typically arise. Moreover, neuroblastoma cells produce leukotrienes, and stimulation of neuroblastoma cells with leukotrienes increased neuroblastoma cell viability. Inhibitors of 5-LO (AA-861), FLAP (MK-886), or the leukotriene receptor antagonist montelukast inhibited neuroblastoma cell growth by induction of G(1)-cell cycle arrest and apoptosis. Similarly, specific 5-LO and leukotriene receptor silencing by small interfering RNA decreased neuroblastoma cell growth. These findings provide new insights into the pathobiology of neuroblastoma, and the use of leukotriene pathway inhibitors as a novel adjuvant therapy for children with neuroblastoma warrants further consideration." @default.
- W2024224319 created "2016-06-24" @default.
- W2024224319 creator A5030830565 @default.
- W2024224319 creator A5054970430 @default.
- W2024224319 creator A5055520688 @default.
- W2024224319 creator A5064224860 @default.
- W2024224319 creator A5068603373 @default.
- W2024224319 creator A5078279094 @default.
- W2024224319 creator A5078378771 @default.
- W2024224319 creator A5080886895 @default.
- W2024224319 creator A5082042696 @default.
- W2024224319 creator A5022014183 @default.
- W2024224319 date "2008-06-30" @default.
- W2024224319 modified "2023-10-18" @default.
- W2024224319 title "Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy" @default.
- W2024224319 cites W1541709451 @default.
- W2024224319 cites W1671834350 @default.
- W2024224319 cites W1791469918 @default.
- W2024224319 cites W1922287625 @default.
- W2024224319 cites W1936798053 @default.
- W2024224319 cites W1965037168 @default.
- W2024224319 cites W1968890803 @default.
- W2024224319 cites W1969104374 @default.
- W2024224319 cites W1969154550 @default.
- W2024224319 cites W1972439638 @default.
- W2024224319 cites W1983310583 @default.
- W2024224319 cites W1990404670 @default.
- W2024224319 cites W1993721507 @default.
- W2024224319 cites W1994325899 @default.
- W2024224319 cites W1995783979 @default.
- W2024224319 cites W1997445104 @default.
- W2024224319 cites W1997561160 @default.
- W2024224319 cites W2000201916 @default.
- W2024224319 cites W2004351423 @default.
- W2024224319 cites W2004942960 @default.
- W2024224319 cites W2007187686 @default.
- W2024224319 cites W2014768234 @default.
- W2024224319 cites W2018666623 @default.
- W2024224319 cites W2036299072 @default.
- W2024224319 cites W2036355263 @default.
- W2024224319 cites W2038462526 @default.
- W2024224319 cites W2038575244 @default.
- W2024224319 cites W2039207394 @default.
- W2024224319 cites W2048675742 @default.
- W2024224319 cites W2050669947 @default.
- W2024224319 cites W2051890167 @default.
- W2024224319 cites W2052646547 @default.
- W2024224319 cites W2060736868 @default.
- W2024224319 cites W2064700667 @default.
- W2024224319 cites W2065297082 @default.
- W2024224319 cites W2067606868 @default.
- W2024224319 cites W2074322303 @default.
- W2024224319 cites W2076124116 @default.
- W2024224319 cites W2076536269 @default.
- W2024224319 cites W2079782583 @default.
- W2024224319 cites W2079895882 @default.
- W2024224319 cites W2085029013 @default.
- W2024224319 cites W2089087441 @default.
- W2024224319 cites W2091211658 @default.
- W2024224319 cites W2093126094 @default.
- W2024224319 cites W2101668331 @default.
- W2024224319 cites W2103238639 @default.
- W2024224319 cites W2105594396 @default.
- W2024224319 cites W2118768954 @default.
- W2024224319 cites W2132182857 @default.
- W2024224319 cites W2133514206 @default.
- W2024224319 cites W2138305526 @default.
- W2024224319 cites W2138713668 @default.
- W2024224319 cites W2145492158 @default.
- W2024224319 cites W2156043983 @default.
- W2024224319 cites W2160234181 @default.
- W2024224319 cites W2166982073 @default.
- W2024224319 cites W2167686417 @default.
- W2024224319 cites W2170795266 @default.
- W2024224319 cites W2199916120 @default.
- W2024224319 doi "https://doi.org/10.1096/fj.07-103457" @default.
- W2024224319 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18591367" @default.
- W2024224319 hasPublicationYear "2008" @default.
- W2024224319 type Work @default.
- W2024224319 sameAs 2024224319 @default.
- W2024224319 citedByCount "60" @default.
- W2024224319 countsByYear W20242243192012 @default.
- W2024224319 countsByYear W20242243192013 @default.
- W2024224319 countsByYear W20242243192014 @default.
- W2024224319 countsByYear W20242243192015 @default.
- W2024224319 countsByYear W20242243192016 @default.
- W2024224319 countsByYear W20242243192017 @default.
- W2024224319 countsByYear W20242243192018 @default.
- W2024224319 countsByYear W20242243192019 @default.
- W2024224319 countsByYear W20242243192020 @default.
- W2024224319 countsByYear W20242243192021 @default.
- W2024224319 countsByYear W20242243192022 @default.
- W2024224319 countsByYear W20242243192023 @default.
- W2024224319 crossrefType "journal-article" @default.
- W2024224319 hasAuthorship W2024224319A5022014183 @default.
- W2024224319 hasAuthorship W2024224319A5030830565 @default.
- W2024224319 hasAuthorship W2024224319A5054970430 @default.
- W2024224319 hasAuthorship W2024224319A5055520688 @default.